Communiqués Core One Labs Inc. Deutsche Boerse AG

Actions

LD6

CA21872J3073

Marché Fermé - Deutsche Boerse AG Autres places de cotation 20:18:43 31/05/2024			Varia. 5j.	Varia. 1 janv.
0,13 ^EUR	+3,17 %		-.--%	-43,48 %

29/02	Core One Labs Inc. annonce ses résultats pour le troisième trimestre et les neuf mois clos le 31 décembre 2023	CI
2023	Core One Labs Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 septembre 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Core One Labs : Announces Extension of Non-Brokered Private Placement	16/05	PU
Core One Labs : Announces Non-Brokered Private Placement	09/04	PU
Core One Labs : Announces Non-Brokered Private Placement	11/09/23	PU
Core One Labs : Commends Study Exploring Psychedelics’ Efficacy in Providing Relief for Chronic Pain Conditions	24/08/23	PU
Core One Labs : Applauds Groundbreaking Research on Psilocybin as a Potential Anorexia Treatment	04/08/23	PU
Core One Labs : Applauds California Assembly Health Committee’s Approval of Bill to Legalize Psychedelics	19/07/23	PU
Core One Labs : Applauds FDA’s Draft Guidance on Clinical Trials for Psychedelic Drugs	27/06/23	PU
Core One's Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing Facility	24/04/23	AQ
Core One Labs Applauds Study Linking Psychedelic Treatment to Substantial Reduction in Alcohol Misuse and PTSD Symptoms in US Special Operations Forces Veterans	05/04/23	AQ
Core One Labs : Applauds Study Linking Psychedelic Treatment to Substantial Reduction in Alcohol Misuse & PTSD Symptoms in US Special Operations Forces Veterans	04/04/23	PU
Core One Labs' Acquires GMP Drug Inc. Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and other Drug Developers	16/01/23	AQ
Core One Labs' Subsidiary Vocan Biotechnologies Achieves Development Milestones	14/12/22	AQ
Core One Labs : rsquo; Subsidiary Vocan Biotechnologies Achieves Development Milestones	13/12/22	PU
CORE ONE LABS' ANNOUNCES APPOINTMENT OF BF BORGERS CPA PC AS ITS NEW AUDITOR	28/11/22	AQ
Core One Labs Prepares for Commercial Production of API-Grade Psilocybin Plans Initial Production Run at GMP Facility in January	21/11/22	AQ
Core One Labs : Announces Grant of Stock Options	10/11/22	PU
Core One Labs : Announces Grant of Restricted Share Units	09/11/22	PU
Core One Labs Takes Next Steps to Prepare for Potential Takeover Opportunities	24/10/22	AQ
European University to Fund Core One Labs Akome Advanced Neurogenesis Stimulation Studies	17/10/22	AQ
Core One Labs Nearing GMP Production as Canada's Province of Alberta Announces Game Changing Legislation	10/10/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Core One Labs Inc. Deutsche Boerse AG

Actions

LD6

CA21872J3073

Communiqués

Filtres